InvestorsHub Logo
Followers 11
Posts 1363
Boards Moderated 0
Alias Born 07/03/2018

Re: MiamiGent post# 38707

Thursday, 08/26/2021 8:49:48 PM

Thursday, August 26, 2021 8:49:48 PM

Post# of 40501
"The obvious " On Aug. 26 2021 INO receives authorization to conduct phase 3 efficacy trial of it's Covid -19 DNA vaccine candidate INO -4800. Seems obvious we are moving on. "INO"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News